ABP-700, identified by its CAS number 1446482-29-6, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential applications in pharmacology. It is characterized as a selective antagonist of certain receptors, which may contribute to its therapeutic effects. The compound is typically studied for its role in modulating neurotransmitter systems, potentially impacting conditions such as anxiety or depression. Its molecular structure includes specific functional groups that enhance its binding affinity and selectivity for target receptors. Additionally, ABP-700's pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion, are crucial for determining its efficacy and safety profile in clinical settings. Research into ABP-700 continues to evolve, with ongoing studies aimed at elucidating its mechanism of action and potential therapeutic applications. As with any investigational compound, comprehensive studies are necessary to fully understand its biological effects and therapeutic potential.

ABP-700

1446482-29-6: ABP-700, identified by its CAS number 1446482-29-6, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential applications in pharmacology. It is characterized as a selective antagonist of certain receptors, which may contribute to its therapeutic effects. The compound is typically studied for its role in modulating neurotransmitter systems, potentially impacting conditions such as anxiety or depression. Its molecular structure includes specific functional groups that enhance its binding affinity and selectivity for target receptors. Additionally, ABP-700's pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion, are crucial for determining its efficacy and safety profile in clinical settings. Research into ABP-700 continues to evolve, with ongoing studies aimed at elucidating its mechanism of action and potential therapeutic applications. As with any investigational compound, comprehensive studies are necessary to fully understand its biological effects and therapeutic potential.

<p>ABP-700 is a positive allosteric modulator of the GABAA receptor.</p>

CAS 1446482-29-6

ABP-700

ABP-700

Ref: TM-T26521